Literature DB >> 34913014

Transcatheter aortic valve replacement for aortic regurgitation in Asians: TAVR for aortic regurgitation in Asians.

Erica L Soong1, Yi Jing Ong1, Jamie S Y Ho2, Nichola W S Chew3, William K F Kong3, Tiong-Cheng Yeo3, Ping Chai3, Edgar L W Tay3, Kent Tan3, Yinghao Lim3, Ivandito Kuntjoro3, Ching-Hui Sia3.   

Abstract

AIMS: Although surgical aortic valve replacement (SAVR) is currently the recommended intervention for patients with native AR without aortic stenosis, a significant proportion of Asian patients undergo transcatheter aortic valve replacement (TAVR), which has not been studied fully for safety and outcomes. This systematic review aims to examine the characteristics and outcomes of Asian patients with pure native aortic regurgitation (AR) undergoing TAVR. METHODS AND
RESULTS: PubMed, Embase, Scopus, Web of Science and Cochrane CENTRAL were systematically searched for randomised controlled trials, observational studies and case reports published  from inception to 2 April 2020, involving patients of Asian ethnicity with pure native aortic regurgitation who had undergone TAVR. Our primary outcome was all-cause mortality, with secondary outcomes including all major complications. Five studies (n=274 patients) and eight case reports were included. Device success was reported in 94.9% of the patients, the all-cause mortality rate was 4.4%, 2.5% were converted to SAVR, 1.7% had post-operative paravalvular leak and 6.7% required permanent pacemaker implantation.
CONCLUSIONS: TAVR has demonstrated acceptable safety and efficacy in Asian patients with pure AR displaying low mortality rates and few adverse outcomes.

Entities:  

Year:  2021        PMID: 34913014      PMCID: PMC8670568          DOI: 10.4244/AIJ-D-21-00007

Source DB:  PubMed          Journal:  AsiaIntervention        ISSN: 2426-3958


  25 in total

1.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

2.  A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system.

Authors:  Mingwui Tung; Xu Wang; Fei Li; Hao Wang; Yingqiang Guo; Chunsheng Wang; Lai Wei; Xinjin Luo; Xin Wang; Wei Wang
Journal:  J Cardiol       Date:  2018-07-29       Impact factor: 3.159

3.  Predictors of Long-Term Outcome of Isolated Surgical Aortic Valve Replacement in Aortic Regurgitation With Reduced Left Ventricular Ejection Fraction and Extreme Left Ventricular Dilatation.

Authors:  Nianguo Dong; Weiwei Jiang; Ping Yin; Xingjian Hu; Yin Wang
Journal:  Am J Cardiol       Date:  2020-02-08       Impact factor: 2.778

4.  Changes in left ventricular function in patients with aortic regurgitation 12 months after transapical transcatheter aortic valve implantation.

Authors:  Ming-Dan Deng; Xin Wei; Xiao-Ling Zhang; Xiao-Dong Li; Gu-Yue Liu; Da Zhu; Ying-Qiang Guo; Hong Tang
Journal:  Int J Cardiovasc Imaging       Date:  2018-09-27       Impact factor: 2.357

5.  Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve.

Authors:  Huan Liu; Ye Yang; Wenshuo Wang; Da Zhu; Lai Wei; Kefang Guo; Weipeng Zhao; Xue Yang; Liming Zhu; Yingqiang Guo; Wei Wang; Chunsheng Wang
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-13       Impact factor: 5.209

6.  Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population.

Authors:  Sung-Han Yoon; Jung-Min Ahn; Kentaro Hayashida; Yusuke Watanabe; Shinichi Shirai; Hsien-Li Kao; Wei-Hsian Yin; Michael Kang-Yin Lee; Edgar Tay; Motoharu Araki; Futoshi Yamanaka; Takahide Arai; Mao-Shin Lin; Jun-Bean Park; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Toshiya Muramatsu; Michiya Hanyu; Ken Kozuma; Hyo-Soo Kim; Shigeru Saito; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2016-05-09       Impact factor: 11.195

7.  Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.

Authors:  Henrique B Ribeiro; John G Webb; Raj R Makkar; Mauricio G Cohen; Samir R Kapadia; Susheel Kodali; Corrado Tamburino; Marco Barbanti; Tarun Chakravarty; Hasan Jilaihawi; Jean-Michel Paradis; Fabio S de Brito; Sergio J Cánovas; Asim N Cheema; Peter P de Jaegere; Raquel del Valle; Paul T L Chiam; Raúl Moreno; Gonzalo Pradas; Marc Ruel; Jorge Salgado-Fernández; Rogerio Sarmento-Leite; Hadi D Toeg; James L Velianou; Alan Zajarias; Vasilis Babaliaros; Fernando Cura; Antonio E Dager; Ganesh Manoharan; Stamatios Lerakis; Augusto D Pichard; Sam Radhakrishnan; Marco Antonio Perin; Eric Dumont; Eric Larose; Sergio G Pasian; Luis Nombela-Franco; Marina Urena; E Murat Tuzcu; Martin B Leon; Ignacio J Amat-Santos; Jonathon Leipsic; Josep Rodés-Cabau
Journal:  J Am Coll Cardiol       Date:  2013-08-14       Impact factor: 24.094

8.  Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.

Authors:  Samir R Kapadia; E Murat Tuzcu; Raj R Makkar; Lars G Svensson; Shikhar Agarwal; Susheel Kodali; Gregory P Fontana; John G Webb; Michael Mack; Vinod H Thourani; Vasilis C Babaliaros; Howard C Herrmann; Wilson Szeto; Augusto D Pichard; Mathew R Williams; William N Anderson; Jodi J Akin; D Craig Miller; Craig R Smith; Martin B Leon
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

9.  Methodological quality and synthesis of case series and case reports.

Authors:  Mohammad Hassan Murad; Shahnaz Sultan; Samir Haffar; Fateh Bazerbachi
Journal:  BMJ Evid Based Med       Date:  2018-02-02

Review 10.  TAVI for Pure Native Aortic Regurgitation: Are We There Yet?

Authors:  Eduardo A Arias; Amit Bhan; Zhan Y Lim; Michael Mullen
Journal:  Interv Cardiol       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.